These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28711864)

  • 21. Predictive factors for better bypass patency and limb salvage after prosthetic above-knee bypass reconstruction.
    Klingelhoefer E; Bergert H; Kersting S; Ludwig S; Weiss N; Schönleben F; Grützmann R; Gäbel G
    J Vasc Surg; 2016 Aug; 64(2):380-388.e1. PubMed ID: 27763266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased epicardial adipose tissue thickness is a predictor of new-onset diabetes mellitus in patients with coronary artery disease treated with high-intensity statins.
    Kang J; Kim YC; Park JJ; Kim S; Kang SH; Cho YJ; Yoon YE; Oh IY; Yoon CH; Suh JW; Cho YS; Youn TJ; Chae IH; Choi DJ
    Cardiovasc Diabetol; 2018 Jan; 17(1):10. PubMed ID: 29325562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcomes with high-intensity statins according to atherothrombotic risk stratification after acute myocardial infarction: The FAST-MI registries.
    Desjobert E; Tea V; Schiele F; Ferrières J; Simon T; Danchin N; Puymirat E;
    Arch Cardiovasc Dis; 2021 Feb; 114(2):88-95. PubMed ID: 33011156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Statin Treatment Intensity after Endovascular Revascularization on Lower Extremity Peripheral Artery Disease.
    Kim GS; Seo J; Kim BG; Jin MN; Lee HY; Kim BO; Byun YS
    Yonsei Med J; 2022 Apr; 63(4):333-341. PubMed ID: 35352884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term results of plaque excision combined with aggressive pharmacotherapy in high-risk patients with advanced peripheral artery disease (SAVE a LEG registry).
    Kiesz RS; Wiernek SL; Wiernek BK; Radvany MG; Buszman PP; Szymanski R; Konkolewska MD; Martin JL; Buszman PE
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):E244-50. PubMed ID: 23172729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Statin Therapy and Dose on Cardiovascular and Limb Outcomes in Peripheral Arterial Disease: A Systematic Review and Meta-analysis.
    Sofat S; Chen X; Chowdhury MM; Coughlin PA
    Eur J Vasc Endovasc Surg; 2021 Sep; 62(3):450-461. PubMed ID: 34389230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).
    Bonaca MP; Nault P; Giugliano RP; Keech AC; Pineda AL; Kanevsky E; Kuder J; Murphy SA; Jukema JW; Lewis BS; Tokgozoglu L; Somaratne R; Sever PS; Pedersen TR; Sabatine MS
    Circulation; 2018 Jan; 137(4):338-350. PubMed ID: 29133605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Collective impact of conventional cardiovascular risk factors and coronary calcium score on clinical outcomes with or without statin therapy: The St Francis Heart Study.
    Waheed S; Pollack S; Roth M; Reichek N; Guerci A; Cao JJ
    Atherosclerosis; 2016 Dec; 255():193-199. PubMed ID: 27693004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy.
    Foody JM; Toth PP; Tomassini JE; Sajjan S; Ramey DR; Neff D; Tershakovec AM; Hu H; Tunceli K
    Vasc Health Risk Manag; 2013; 9():719-27. PubMed ID: 24265554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics and outcomes of patients with peripheral artery disease undergoing endovascular revascularization: A community hospital perspective.
    Michael Gharacholou S; Li Z; Uy JJ; Eckstein LH; Flock CR; Senger JL; Gutierrez JFT; Chapman SC
    Vascular; 2021 Jun; 29(3):372-379. PubMed ID: 32951559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Statins on Survival and Limb Salvage in Patients Undergoing Peripheral Endovascular Intervention for Chronic Limb-Threatening Ischemia.
    Chang M; O'Brien-Irr M; Montross B; Dosluoglu H; Harris L; Dryjski M; Rivero M; Khan SZ
    Ann Vasc Surg; 2023 Apr; 91():20-27. PubMed ID: 36503021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of statin treatment after endovascular therapy for isolated below-the-knee disease in patients with critical limb ischemia.
    Tomoi Y; Soga Y; Iida O; Hirano K; Suzuki K; Kawasaki D; Yamauchi Y; Miyashita Y; Tazaki J; Nobuyoshi M
    Cardiovasc Interv Ther; 2013 Oct; 28(4):374-82. PubMed ID: 23756936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins.
    Fox KM; Tai MH; Kostev K; Hatz M; Qian Y; Laufs U
    Clin Res Cardiol; 2018 May; 107(5):380-388. PubMed ID: 29273856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease.
    Armstrong EJ; Chen DC; Westin GG; Singh S; McCoach CE; Bang H; Yeo KK; Anderson D; Amsterdam EA; Laird JR
    J Am Heart Assoc; 2014 Apr; 3(2):e000697. PubMed ID: 24721799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High Apolipoprotein E Levels Predict Adverse Limb Events in Patients with Peripheral Artery Disease Due to Peripheral Artery Disease Undergoing Endovascular Treatment and On-Statin Treatment.
    Fukase T; Dohi T; Kato Y; Chikata Y; Takahashi N; Endo H; Doi S; Nishiyama H; Okai I; Iwata H; Okazaki S; Isoda K; Miyauchi K; Daida H; Minamino T
    Int Heart J; 2021 Jul; 62(4):872-878. PubMed ID: 34276016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery Disease: A Randomized Clinical Trial.
    Hong SJ; Lee YJ; Lee SJ; Hong BK; Kang WC; Lee JY; Lee JB; Yang TH; Yoon J; Ahn CM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK;
    JAMA; 2023 Apr; 329(13):1078-1087. PubMed ID: 36877807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of Blood Lipid Management in Patients With Peripheral Artery Disease.
    Hess CN; Cannon CP; Beckman JA; Goodney PP; Patel MR; Hiatt WR; Mues KE; Orroth KK; Shannon E; Bonaca MP
    J Am Coll Cardiol; 2021 Jun; 77(24):3016-3027. PubMed ID: 34140105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statin Prescription Rates, Adherence, and Associated Clinical Outcomes Among Women with PAD and ICVD.
    Mahtta D; Ahmed ST; Ramsey DJ; Akeroyd JM; Lee MT; Rodriguez F; Michos ED; Itchhaporia D; Nasir K; Alam M; Jneid H; Ballantyne CM; Petersen LA; Virani SS
    Cardiovasc Drugs Ther; 2020 Dec; 34(6):745-754. PubMed ID: 32840709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different diabetogenic effect of statins according to intensity and dose in patients with acute myocardial infarction: a nationwide cohort study.
    Lee J; Choi JY; Choi BG; Choi YJ; Park S; Kang DO; Park EJ; Kim JB; Roh SY; Na JO; Choi CU; Kim EJ; Park CG; Jeong MH; Hwang JY; Hur SH; Jeong JO; Oh S; Rha SW;
    Sci Rep; 2024 Aug; 14(1):19438. PubMed ID: 39169014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time trends analysis of statin prescription prevalence, therapy initiation, dose intensity, and utilization from the hospital information system of Jinshan Hospital, Shanghai (2012-2018).
    Liu Y; Lv X; Xie N; Fang Z; Ren W; Gong Y; Jin Y; Zhang J
    BMC Cardiovasc Disord; 2020 Apr; 20(1):201. PubMed ID: 32334525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.